P17.89 EFFECTS OF GLIOBLASTOMA FIRST-LINE TRIALS ON TIME DELAY TO INITIATION OF TREATMENT, SIGNS OF EARLY TUMOR PROGRESSION AND PROGRESSION-FREE SURVIVAL

Por Sefranek, D., Wendl, C., Hutterer, M., Hau, P., Uhl, M.
Publicado em 2014

O7.04 DCE-MRI DISCRIMINATES BETWEEN RESPONDER AND NON-RESPONDER IN RECURRENT HIGH-GRADE GLIOMA PATIENTS UNDERGOING ANTI-ANGIOGENIC TREATMENT

Por Nowosielski, M., Kremser, C., Schocke, M., Gizewski, E., Iglseder, S., Muigg, A., Freyschlag, C., Stockhammer, G., Hutterer, M.
Publicado em 2014

P16.10 DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET

Por Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Kebir, S., Goldbrunner, R., Ruge, M.I., Schmidt, M., Langen, K.
Publicado em 2014

O1.03 DENSITY OF TUMOR INFILTRATING LYMPHOCYTES CORRELATES WITH BRAIN EDEMA AND OVERALL SURVIVAL IN BRAIN METASTASES

Por Berghoff, A.S., Wöhrer, A., Hackl, M., Pichler, J., Hutterer, M., Widhalm, G., Dieckmann, K., Prayer, D., Hainfellner, J.A., Preusser, M.
Publicado em 2014